Grants and Contributions:
Title:
515732
Agreement Number:
515732
Agreement Value:
$10,994,000.00
Agreement Date:
Jan 1, 2026 - Mar 31, 2030
Description:
A proposal to scale up production, complete preclinical studies, and launch first in human clinical trials for a world-first, dual-use universal blood and organ platform.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
Advance Canada?s scientific, technological and industrial capabilities that can be deployed during health emergencies; and grow and sustain a competitive and innovative life sciences ecosystem that develops the next generation of medicines and technology platforms in Canada.
Location:
VANCOUVER, British Columbia, CA V6E 4E5
Reference Number:
033-2025-2026-Q4-515732
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
706842473
Recipient Type:
For-profit organization
Additional Information:
2025/26 to 2029/30,
Recipient's Operating Name:
Avivo Biomedical Inc
Recipient's Legal Name:
Avivo Biomedical Inc
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Life Sciences Fund Contributions
Program Purpose:
Misson-driven fund with a dual mandate to advance and strengthen Canada?s scientific, technological and industrial capabilities that can be deployed during health emergencies; and grow and sustain a competitive and innovative life sciences ecosystem that develops the next generation of medicines and technology platforms in Canada.
NAICS Code:
621510